Selective PARP1 inhibitors, PARP1-based dual-target inhibitors, PROTAC PARP1 degraders, and prodrugs of PARP1 inhibitors for cancer therapy

Peng, XP; Pan, WY; Jiang, F; Chen, WM; Qi, ZT; Peng, WJ; Chen, JJ

Peng, WJ (通讯作者),Gannan Med Univ, Sch Pharm, Key Lab Prevent & Treatment Cardiovasc & Cerebrova, Minist Educ,Jiangxi Prov Key Lab Biomat & Biofabri, Ganzhou 314000, Peoples R China.;Chen, JJ (通讯作者),Southern Med Univ, Sch Pharmaceut Sci, Guangdong Prov Key Lab New Drug Screening, NMPA Key Lab Res & Evaluat Drug Metab, Guangzhou 510515, Peoples R China.

PHARMACOLOGICAL RESEARCH, 2022; 186 ():